So as an expert in GLP-1s, does she think Im a good candidate
Read more Discover how Dose AI transforms GLP-1 medication tracking with smart, personalized digital health support
An accompanying conference abstract and poster, presented at the 31st European Congress on Obesity in May 2024, also indicated that patients may derive cardiovascular benefit from semaglutide regardless of weight loss
Hormonal and neural mechanisms of food reward, eating behaviour and obesity
Etiology Genetics COL5A1 or COL5A2 mutation in 40-50% less common mutations identified below Associated conditions Connective tissue disorder characterized by Classification Berlin Classification (1988) - revised Types I - XI exist Villefranche Classification (1998) Presentation Symptoms double-jointedness easily damaged, bruised, & stretchy skin easy scarring & poor wound healing increased joint mobility, joint popping, early arthritis chronic musculoskeletal pain (50%) Physical exam a score of 5 or more on 9-point Beighton-Horan scale defines joint hypermobility
